As Therapeutic Modalities Expand, Genomic Profiling Must Keep Pace
The boundaries of what’s considered “druggable” are shifting as advances in cell and gene therapies expand the possibilities for cancer treatment. Expanded insights can open new avenues for biomarker research and therapeutic discovery. The post As Therapeutic Modalities Expand, Genomic Profiling Must Keep Pace appeared first on GEN - Genetic Engineering and Biotechnology News .
The boundaries of what’s considered “druggable” are shifting as advances in cell and gene therapies expand the possibilities for cancer treatment. Expanded insights can open new avenues for biomarker research and therapeutic discovery. The post As Therapeutic Modalities Expand, Genomic Profiling Must Keep Pace appeared first on GEN - Genetic Engineering and Biotechnology News .
This is a summary of the story. Read the full article at GEN — Genetic Engineering & Biotechnology News ↗